Intestinal permeability in a patient with liver cirrhosis

被引:35
作者
Aguirre Valadez, Jonathan Manuel [1 ]
Rivera-Espinosa, Liliana [2 ]
Mendez-Guerrero, Osvely [1 ]
Luis Chavez-Pacheco, Juan [2 ]
Garcia Juarez, Ignacio [1 ]
Torre, Aldo [1 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador, Dept Gastroenterol, Mexico City, DF, Mexico
[2] Inst Nacl Pediat, Pharmacol Lab, Mexico City, DF, Mexico
关键词
liver cirrhosis; hepatic encephalopathy; spontaneous bacterial peritonitis; variceal hemorrhage; bacterial translocation; intestinal permeability; SPONTANEOUS BACTERIAL PERITONITIS; PERFORMANCE LIQUID-CHROMATOGRAPHY; MUCOSAL BARRIER FUNCTION; CAPILLARY-ZONE-ELECTROPHORESIS; PRIMARY BILIARY-CIRRHOSIS; TUMOR-NECROSIS-FACTOR; HEPATIC-ENCEPHALOPATHY; TIGHT JUNCTIONS; EPITHELIAL-CELLS; CROHNS-DISEASE;
D O I
10.2147/TCRM.S115902
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
100404 [儿少卫生与妇幼保健学];
摘要
Liver cirrhosis is a worldwide public health problem, and patients with this disease are at high risk of developing complications, bacterial translocation from the intestinal lumen to the mesenteric nodes, and systemic circulation, resulting in the development of severe complications related to high mortality rate. The intestinal barrier is a structure with a physical and biochemical activity to maintain balance between the external environment, including bacteria and their products, and the internal environment. Patients with liver cirrhosis develop a series of alterations in different components of the intestinal barrier directly associated with the severity of liver disease that finally increased intestinal permeability. A "leaky gut" is an effect produced by damaged intestinal barrier; alterations in the function of tight junction proteins are related to bacterial translocation and their products. Instead, increasing serum proinflammatory cytokines and hemodynamics modification, which results in the appearance of complications of liver cirrhosis such as hepatic encephalopathy, variceal hemorrhage, bacterial spontaneous peritonitis, and hepatorenal syndrome. The intestinal microbiota plays a fundamental role in maintaining the proper function of the intestinal barrier; bacterial over-growth and dysbiosis are two phenomena often present in people with liver cirrhosis favoring bacterial translocation. Increased intestinal permeability has an important role in the genesis of these complications, and treating it could be the base for prevention and partial treatment of these complications.
引用
收藏
页码:1729 / 1748
页数:20
相关论文
共 147 条
[1]
The role of the gut microbiota in nonalcoholic fatty liver disease [J].
Abu-Shanab, Ahmed ;
Quigley, Eamonn M. M. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2010, 7 (12) :691-701
[2]
Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement [J].
Albillos, A ;
de la Hera, A ;
González, M ;
Moya, JL ;
Calleja, JL ;
Monserrat, J ;
Ruiz-del-Arbol, L ;
Alvarez-Mon, M .
HEPATOLOGY, 2003, 37 (01) :208-217
[3]
Activated macrophages inhibit enterocyte gap junctions via the release of nitric oxide [J].
Anand, Rahul J. ;
Dai, Shipan ;
Rippel, Christopher ;
Leaphart, Cynthia ;
Qureshi, Faisal ;
Gribar, Steven C. ;
Kohler, Jeff W. ;
Li, Jun ;
Stolz, Donna Beer ;
Sodhi, Chhinder ;
Hackam, David J. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2008, 294 (01) :G109-G119
[4]
Angeli P, 2010, HEPATOLOGY, V52, p342A
[5]
Nucleotide-Binding Oligomerization Domain Containing 2 (NOD2) Variants Are Genetic Risk Factors for Death and Spontaneous Bacterial Peritonitis in Liver Cirrhosis [J].
Appenrodt, Beate ;
Gruenhage, Frank ;
Gentemann, Martin G. ;
Thyssen, Lydia ;
Sauerbruch, Tilman ;
Lammert, Frank .
HEPATOLOGY, 2010, 51 (04) :1327-1333
[6]
Altered intestinal tight junctions' expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability [J].
Assimakopoulos, Stelios F. ;
Tsamandas, Athanassios C. ;
Tsiaoussis, Georgios I. ;
Karatza, Elli ;
Triantos, Christos ;
Vagianos, Constantine E. ;
Spiliopoulou, Iris ;
Kaltezioti, Valeria ;
Charonis, Aristidis ;
Nikolopoulou, Vassiliki N. ;
Scopa, Chrisoula D. ;
Thomopoulos, Konstantinos C. .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (04) :439-446
[7]
Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy [J].
Bajaj, Jasmohan S. ;
Betrapally, Naga S. ;
Hylemon, Phillip B. ;
Heuman, Douglas M. ;
Daita, Kalyani ;
White, Melanie B. ;
Unser, Ariel ;
Thacker, Leroy R. ;
Sanyal, Arun J. ;
Kang, Dae Joong ;
Sikaroodi, Masoumeh ;
Gillevet, Patrick M. .
HEPATOLOGY, 2015, 62 (04) :1260-1271
[8]
Altered profile of human gut microbiome is associated with cirrhosis and its complications [J].
Bajaj, Jasmohan S. ;
Heuman, Douglas M. ;
Hylemon, Phillip B. ;
Sanyal, Arun J. ;
White, Melanie B. ;
Monteith, Pamela ;
Noble, Nicole A. ;
Unser, Ariel B. ;
Daita, Kalyani ;
Fisher, Andmorgan R. ;
Sikaroodi, Masoumeh ;
Gillevet, Patrick M. .
JOURNAL OF HEPATOLOGY, 2014, 60 (05) :940-947
[9]
Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy [J].
Bajaj, Jasmohan S. ;
Heuman, Douglas M. ;
Sanyal, Arun J. ;
Hylemon, Phillip B. ;
Sterling, Richard K. ;
Stravitz, R. Todd ;
Fuchs, Michael ;
Ridlon, Jason M. ;
Daita, Kalyani ;
Monteith, Pamela ;
Noble, Nicole A. ;
White, Melanie B. ;
Fisher, Andmorgan ;
Sikaroodi, Masoumeh ;
Rangwala, Huzefa ;
Gillevet, Patrick M. .
PLOS ONE, 2013, 8 (04)
[10]
Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation [J].
Bajaj, Jasmohan S. ;
Hylemon, Phillip B. ;
Ridlon, Jason M. ;
Heuman, Douglas M. ;
Daita, Kalyani ;
White, Melanie B. ;
Monteith, Pamela ;
Noble, Nicole A. ;
Sikaroodi, Masoumeh ;
Gillevet, Patrick M. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2012, 303 (06) :G675-G685